Tavarnelle Val di Pesa, Italy

Silvana Savino

USPTO Granted Patents = 3 


Average Co-Inventor Count = 6.3

ph-index = 1


Location History:

  • Tavarnelle Val di Pesa, IT (2018 - 2019)
  • Taverna Val di Pesa, IT (2020)

Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Silvana Savino: Innovator in Meningococcal Vaccine Development

Introduction

Silvana Savino is a prominent inventor based in Tavarnelle Val di Pesa, Italy. She has made significant contributions to the field of vaccine development, particularly in the area of meningococcal vaccines. With a total of 3 patents to her name, her work is crucial in addressing vaccine coverage issues.

Latest Patents

Savino's latest patents focus on adjuvanted combinations of meningococcal factor H binding proteins. One of her notable inventions addresses the poor coverage of the M01573 sequence of meningococcal fHbp in vaccines. This invention proposes a fHbp-based vaccine that includes two family I fHbp sequences, one closely related to MC58 and the other to M01573. Additionally, her multi-family fHbp-based vaccine combines a family I fHbp sequence with a family III fHbp sequence, both adjuvanted with aluminium phosphate.

Career Highlights

Savino is currently employed at GlaxoSmithKline Biologicals SA, where she continues her research and development efforts in vaccine technology. Her innovative approaches have positioned her as a key figure in the field, contributing to advancements in public health.

Collaborations

Throughout her career, Savino has collaborated with notable colleagues, including Brunella Brunelli and Maurizio Comanducci. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Silvana Savino's work in meningococcal vaccine development exemplifies her dedication to improving public health through innovation. Her patents and collaborations reflect her commitment to advancing vaccine technology and addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…